Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

SNIPSNP: precision design of CRISPR/Cas9 knock-in reagents for variant correction and disease modeling.

Nucleic acids research·2026
Same author

Surgery for Elderly Patients with Nonfunctional Pituitary Adenomas Appears to Be Safe.

World neurosurgery·2026
Same author

Macrophage Polarization and Spatial Architecture Characterize the Tumor Immune Microenvironment and Prognosis in Hepatoblastoma.

The American journal of pathology·2026
Same author

Efficient NK cell transduction with VSV-G-pseudotyped lentiviral vectors.

Molecular therapy. Advances·2026
Same author

Homozygous loss-of-function mutation in SIT1 leads to combined immunodeficiency due to dysregulated T-cell receptor signaling.

The Journal of allergy and clinical immunology·2026
Same author

Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.

Cancer research·2026

相关实验视频

Updated: Jul 1, 2026

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

24.3K

针对免疫的先天性错误的精密T细胞校正平台.

Katariina Mamia1, Solrun Kolbeinsdottir2, Kornel Labun3

  • 1Centre for Molecular Medicine Norway, University of Oslo; Oslo, 0318, Norway; Department of Pediatrics, Oslo University Hospital; Oslo, 0372, Norway; Precision Immunotherapy Alliance, University of Oslo; Oslo, 0379, Norway.

Molecular therapy : the journal of the American Society of Gene Therapy
|August 14, 2025
PubMed
概括

这项研究引入了一种精确的CRISPR/Cas9基因编辑工具,用于纠正T细胞中的单基因缺陷,为免疫的先天性错误 (IEI) 提供了一种新的治疗方法,没有有害的副作用.

更多相关视频

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
09:37

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

13.2K
Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation
09:29

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on: February 28, 2025

1.5K

相关实验视频

Last Updated: Jul 1, 2026

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

24.3K
Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
09:37

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

13.2K
Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation
09:29

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on: February 28, 2025

1.5K

科学领域:

  • 免疫学 免疫学 免疫学
  • 基因治疗 基因治疗
  • 分子生物学分子生物学

背景情况:

  • 目前用于免疫的先天性错误 (IEI) 的基因编辑策略可以破坏基因表达.
  • 自主造血干细胞移植不适合所有患者.
  • T细胞基因校正为淋巴细胞IEI提供了替代治疗策略.

研究的目的:

  • 开发和验证一个高效的T细胞单核酸变异 (SNV) 校正平台,使用同质导向修复 (HDR).
  • 在IEI的临床前模型中评估基于HDR的平台的有效性和安全性.

主要方法:

  • 使用同质导向修复 (HDR) 来精确纠正T细胞中的SNV.
  • 采用了IEI模型,包括STAT1功能增益 (STAT1-GOF),软骨头发低质化 (CHH),ADA2缺乏 (DADA2) 和自身免疫多样性肌内膜异位症 - 候群病 - 皮肤外 (APECED).
  • 使用GUIDE-seq,单细胞RNA测序,长读基因组测序和蛋白质组学进行了全面的安全分析.

主要成果:

  • 在选定的IEI模型中达到高达80%的校正效率.
  • 在临床前模型中证明了疾病表型的功能纠正.
  • 经过编辑后确认没有显著的基因组,转录组或蛋白质组异常.

结论:

  • 建立了基于HDR的SNV编辑,作为自主T细胞疗法的可行和便携平台.
  • 这种方法代表了向单一性免疫疾病的宽谱基因校正策略的重大进步.
  • 该平台对治疗各种IEI的临床开发充满希望.